Press release
Investors who lost money with shares of Elanco Animal Health Incorporated (NYSE: ELAN) should contact the Shareholders Foundation in connection with Investigation
An investigation for investors in Elanco Animal Health Incorporated (NYSE: ELAN) shares over potential securities laws violations
Investors who purchased shares of Elanco Animal Health Incorporated (NYSE: ELAN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Elanco Animal Health Incorporated (NYSE: ELAN) concerning whether a series of statements by Elanco Animal Health Incorporated regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Greenfield, IN based Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. Elanco Animal Health Incorporated reported that its annual Total Revenue rose from $4.411 billion in 2022 to $4.417 billion in 2023, and that its Net Loss increased from $78 million in 2022 to over $1.23 billion in 2023.
On June 27, 2024 Elanco Animal Health Incorporated announced "updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro." The press release stated that Zenrelia is expected to receive FDA approval in the third quarter of 2024, leading to a potential commercial launch in the fourth quarter of 2024. The Company had previously set a launch timeline for the third quarter of 2024. The press release also stated that Credelio Quattro is expected to receive FDA approval in the fourth quarter of 2024, while the Company had previously set an approval timeline for the third quarter of 2024.
Shares of Elanco Animal Health Incorporated (NYSE: ELAN) declined from $18.65 per share on June 5, 2024, to $12.57 per share on July 19, 2024.
Those who purchased shares of Elanco Animal Health Incorporated (NYSE: ELAN) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investors who lost money with shares of Elanco Animal Health Incorporated (NYSE: ELAN) should contact the Shareholders Foundation in connection with Investigation here
News-ID: 3620346 • Views: …
More Releases from Shareholders Foundation, Inc.
Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potentia …
An investigation on behalf of current long-term investors in shares of Novo Nordisk A/S (NYSE: NVO) concerning potential breaches of fiduciary duties by certain directors and officers was announced.
Investors who are current long term investors in Novo Nordisk A/S (NYSE: NVO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for long term investors in…
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ …
An investor, who purchased shares of Fortinet, Inc. (NASDAQ: FTNT), filed a lawsuit over alleged violations of Federal Securities Laws by Fortinet, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fortinet, Inc. (NASDAQ: FTNT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 21, 2025. NASDAQ: FTNT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on Octob …
A deadline is coming up on October 07, 2025in the lawsuit filed for certain investors of CTO Realty Growth, Inc. (NYSE: CTO) over alleged securities laws violations by CTO Realty Growth, Inc.
Investors who purchased shares of CTO Realty Growth, Inc. (NYSE: CTO) have certain options and there are strict and short deadlines running. Deadline: October 07, 2025. CTO Realty Growth, Inc. (NYSE: CTO) stockholders should contact the Shareholders Foundation at…
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeu …
An investor, who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR), filed a lawsuit over alleged violations of Federal Securities Laws by Jasper Therapeutics, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 18, 2025. NASDAQ: JSPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Elanco
Animal Healthcare Market Is Booming So Rapidly | Elanco, Vetoquinol, Virbac
The Global Animal Healthcare Market Size is estimated at $72 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 8.8% to reach $153.8 Billion by 2034.
The latest study released on the Global Animal Healthcare Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Animal Healthcare market study covers significant research data and proofs to be a handy resource document for…
Aquaculture Vaccines Market Is Booming Worldwide with Hipra, Nisseiken, Elanco
The "Global Aquaculture Vaccines" intelligence report, just published by USD Analytics, covers insurers' micro-level study of important market niches, product offers, and sales channels. In order to determine market size, potential, growth trends, and competitive environment, the Global Aquaculture Vaccines provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study…
Pet Pharmaceuticals Market is Booming Worldwide with Merck, Elanco, Virbac
The Latest Released Pet Pharmaceuticals market study has evaluated the future growth potential of Pet Pharmaceuticals market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges,…
Animal Pharmaceutical Market May See Big Move | Elanco, Novartis, Nutreco
HTF MI introduce new research on COVID-19 Outbreak-Global Animal Pharmaceutical covering micro level of analysis by competitors and key business segments. The COVID-19 Outbreak-Global Animal Pharmaceutical explores comprehensive study on various segments like opportunities, size, development, innovation, sales and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists both qualitative and quantitative detailing. Some of the Major Key players profiled…
Tylosin Market Challenges,Deep Insights,Trend 2026| Elanco, Huvepharma, Tairui
Complete study of the global Tylosin market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Tylosin industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also provided accurate…
Global Swine Healthcare Market 2018 -Zoetis, Merck, Merial, Elanco
Accord Market, recently published a detailed market research study focused on the “Swine Healthcare Market” across the global, regional and country level. The report provides 360° analysis of “Swine Healthcare Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Swine Healthcare on the…
